GB8605037D0 - Oral pharmaceutical compositions - Google Patents

Oral pharmaceutical compositions

Info

Publication number
GB8605037D0
GB8605037D0 GB868605037A GB8605037A GB8605037D0 GB 8605037 D0 GB8605037 D0 GB 8605037D0 GB 868605037 A GB868605037 A GB 868605037A GB 8605037 A GB8605037 A GB 8605037A GB 8605037 D0 GB8605037 D0 GB 8605037D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
oral
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868605037A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB868605037A priority Critical patent/GB8605037D0/en
Publication of GB8605037D0 publication Critical patent/GB8605037D0/en
Priority to NL8602370A priority patent/NL194822C/en
Priority to HU864004A priority patent/HU197201B/en
Priority to CH3780/86A priority patent/CH669524A5/de
Priority to DE3632201A priority patent/DE3632201C2/en
Priority to GB8623389A priority patent/GB2181053B/en
Priority to DK464686A priority patent/DK170016B1/en
Priority to PT83456A priority patent/PT83456B/en
Priority to IE256586A priority patent/IE59589B1/en
Priority to IL80182A priority patent/IL80182A/en
Priority to NZ217732A priority patent/NZ217732A/en
Priority to SE8604112A priority patent/SE503222C2/en
Priority to KR1019860008136A priority patent/KR920008817B1/en
Priority to AU63226/86A priority patent/AU598751B2/en
Priority to CA000519302A priority patent/CA1298784C/en
Priority to GR862457A priority patent/GR862457B/en
Priority to IT8648494A priority patent/IT1214719B/en
Priority to AT0260486A priority patent/AT402257B/en
Priority to BE1/011554A priority patent/BE905516A/en
Priority to LU86615A priority patent/LU86615A1/en
Priority to ES8602313A priority patent/ES2002508A6/en
Priority to FR868613668A priority patent/FR2589732B1/en
Priority to SG1033/91A priority patent/SG103391G/en
Priority to HK3/92A priority patent/HK392A/en
Priority to CY1622A priority patent/CY1622A/en
Pending legal-status Critical Current

Links

GB868605037A 1985-02-07 1986-02-28 Oral pharmaceutical compositions Pending GB8605037D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions
NL8602370A NL194822C (en) 1985-10-01 1986-09-19 Preparation for oral administration with controlled release and method for its preparation.
HU864004A HU197201B (en) 1985-10-01 1986-09-19 Process for producing oral pharmaceutical compositions of controlled solubility of the active components
CH3780/86A CH669524A5 (en) 1985-10-01 1986-09-22
DE3632201A DE3632201C2 (en) 1985-10-01 1986-09-23 Pharmaceutical composition with sustained release of the active substance
GR862457A GR862457B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
KR1019860008136A KR920008817B1 (en) 1985-10-01 1986-09-29 Process for the preparing pharmaceutical formulations with controlled release of the active substance
DK464686A DK170016B1 (en) 1985-10-01 1986-09-29 Composition with controlled release of the active substance
PT83456A PT83456B (en) 1985-10-01 1986-09-29 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE
IE256586A IE59589B1 (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
IL80182A IL80182A (en) 1985-10-01 1986-09-29 Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance
NZ217732A NZ217732A (en) 1985-10-01 1986-09-29 Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
SE8604112A SE503222C2 (en) 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine
GB8623389A GB2181053B (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
AU63226/86A AU598751B2 (en) 1985-02-07 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
CA000519302A CA1298784C (en) 1985-10-01 1986-09-29 Pharmaceutical formulations with controlled release of the active substance
ES8602313A ES2002508A6 (en) 1985-10-01 1986-09-30 New sustained-release formulation based on pindolol
IT8648494A IT1214719B (en) 1985-10-01 1986-09-30 Controlled release cardiovascular preparations
AT0260486A AT402257B (en) 1985-10-01 1986-09-30 METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF A 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER ACTIVE SUBSTANCE
BE1/011554A BE905516A (en) 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION.
LU86615A LU86615A1 (en) 1985-10-01 1986-09-30 NEW EXTENDED RELEASE FORMULATION
FR868613668A FR2589732B1 (en) 1985-10-01 1986-10-01 NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL
SG1033/91A SG103391G (en) 1985-10-01 1991-12-04 Pharmaceutical formulations with controlled release of the active substance
HK3/92A HK392A (en) 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance
CY1622A CY1622A (en) 1985-10-01 1992-07-10 Pharmaceutical formulations with controlled release of the active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB8605037D0 true GB8605037D0 (en) 1986-04-09

Family

ID=10593875

Family Applications (1)

Application Number Title Priority Date Filing Date
GB868605037A Pending GB8605037D0 (en) 1985-02-07 1986-02-28 Oral pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB8605037D0 (en)

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8708587D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8719387D0 (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8615041D0 (en) Pharmaceutical compositions
GB8605037D0 (en) Oral pharmaceutical compositions
IE861385L (en) Oral pharmaceutical composition
GB8616397D0 (en) Pharmaceutical compositions
GB8630932D0 (en) Pharmaceutical compositions
GB8628476D0 (en) Pharmaceutical compositions
GB8626217D0 (en) Pharmaceutical compositions
GB8626216D0 (en) Pharmaceutical compositions